drugset / Trial / NCT06900816

A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001

NCT06900816

Phase 2 Completed 50 enrolled Chiesi Farmaceutici S.p.A.
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the amount of the study drug, CHF6001, in the blood of adolescent patients with asthma in comparison to adult patients with asthma after a single oral dose of the study drug, CHF 6001.

Timeline

Start
2025-03-28
Primary completion
2025-08-11
Completion
2025-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject TRANIMILAST Small molecule Inhaled

Indications